3 ms·
Plenty of people make money off generics. Even with lower market share you can charge slightly higher prices, but not too high or someone else will undercut. To
by mattnewton 9y ago
Plenty of people make money off generics. Even with lower market share you can charge slightly higher prices, but not too high or someone else will undercut. Today they have a monopoly.
- opportune 9y agoThat's because those generics have already been through the capital intensive process of getting FDA approval. The monopoly is intended to incentivize actually bringing the drug to market. I suppose there are countries without this process, but I also would wager they do not produce nearly as many new drugs (or new orphan drugs) proportionally to the US
- fjsolwmv 9y agoAn orphan drug is by definition a drug with no generics on the market.
- Mz 9y agohttps://en.m.wikipedia.org/wiki/Orphan_drug https://en.m.wikipedia.org/wiki/Orphan_drug An orphan drug is a pharmaceutical agent that has been developed specifically to treat a rare medical condition, the condition itself being referred to as an orphan disease. A rare disease, also referred to as an "orphan disease", is any disease which affects a small percentage of the population. Most rare diseases are genetic
- mirimir 9y agoWell, I was mainly talking about orphan drugs that aren't yet commercialized. Once they're commercialized, they're still called orphan drugs, but maybe that should be "formerly orphan drugs" or whatever. And yes, one of the incentives to encourage commercialization of orphan drugs is extended exclusivity.